These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20367108)

  • 41. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico predictive toxicology: the state-of-the-art and strategies to predict human health effects.
    Helma C
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):27-31. PubMed ID: 15679168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery.
    Freire AC; Basit AW; Choudhary R; Piong CW; Merchant HA
    Int J Pharm; 2011 Aug; 415(1-2):15-28. PubMed ID: 21640175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P; Poggesi I
    Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of gut microbiota in drug response.
    Wilson ID; Nicholson JK
    Curr Pharm Des; 2009; 15(13):1519-23. PubMed ID: 19442168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The early estimation of circulating drug metabolites in humans.
    Luffer-Atlas D
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):985-97. PubMed ID: 22681256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemometric strategy for modeling metabolic biological space along the gastrointestinal tract and assessing microbial influences.
    Martin FP; Montoliu I; Kochhar S; Rezzi S
    Anal Chem; 2010 Dec; 82(23):9803-11. PubMed ID: 21033673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery.
    Arruebo M; Vilaboa N; Santamaria J
    Expert Opin Drug Deliv; 2010 May; 7(5):589-603. PubMed ID: 20230306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The challenges of in silico contributions to drug metabolism in lead optimization.
    Vaz RJ; Zamora I; Li Y; Reiling S; Shen J; Cruciani G
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):851-61. PubMed ID: 20565339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of gut microbiota on drug metabolism.
    Kang MJ; Kim HG; Kim JS; Oh DG; Um YJ; Seo CS; Han JW; Cho HJ; Kim GH; Jeong TC; Jeong HG
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1295-308. PubMed ID: 24033282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the reliability of methods for predicting drug metabolites.
    Johnson M
    J Biopharm Stat; 1991; 1(1):27-56. PubMed ID: 1844690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiological factors with impact on the drug behaviour in the gastrointestinal tract.
    Franc A; Dvořáčková K; Kejdušová M; Goněc R
    Ceska Slov Farm; 2013 Dec; 62(6):243-8. PubMed ID: 24393111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug metabolism in silico - the knowledge-based expert system approach. Historical perspectives and current strategies.
    Long A
    Drug Discov Today Technol; 2013; 10(1):e147-53. PubMed ID: 24050244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro screening of drug metabolism during drug development: can we trust the predictions?
    Pelkonen O; Raunio H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):49-59. PubMed ID: 16922652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Models of the Gut for Analyzing the Impact of Food and Drugs.
    Fois CAM; Le TYL; Schindeler A; Naficy S; McClure DD; Read MN; Valtchev P; Khademhosseini A; Dehghani F
    Adv Healthc Mater; 2019 Nov; 8(21):e1900968. PubMed ID: 31592579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic stability and its role in the discovery of new chemical entities.
    Słoczyńska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Żelaszczyk D; Popiół J; Pękala E
    Acta Pharm; 2019 Sep; 69(3):345-361. PubMed ID: 31259741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic stability studies of lead compounds supported by separation techniques and chemometrics analysis.
    Ulenberg S; Bączek T
    J Sep Sci; 2021 Jan; 44(1):373-386. PubMed ID: 33006800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revisiting the role of gut wall in the fate of orally administered drugs: Why now and to what effect?
    Rostami-Hodjegan A; Tamai I; Pang KS
    Biopharm Drug Dispos; 2017 Mar; 38(2):87-93. PubMed ID: 28317174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.